A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2002
03/27/2002	EP0608341B1 Enzyme-orthokeratology
03/27/2002	CN1342196A Bifidobacterium in treatment of inflammatory disease
03/27/2002	CN1342193A Method for obtaining oil that rich in hydroxyoctadecadienoic fatty acids (hode) or esters thereof from mixture containing linoleic acid or esters thereof
03/27/2002	CN1342169A Oxetanone derivatives
03/27/2002	CN1342099A Chemical method for making pyrithione particle dispersions
03/27/2002	CN1342087A Preparations stabilized over long time
03/27/2002	CN1342084A Therapeutic compositions containing glutathione analogs
03/27/2002	CN1342075A Liposome preparations
03/27/2002	CN1342069A Controlled-release compositions of betahistine
03/27/2002	CN1342068A Core tablet for controlled release of gliclazide after oral administration
03/27/2002	CN1342067A Orally dispersible tablet with low friability and method for preparing same
03/27/2002	CN1342066A Non-invasive vaccination through skin
03/27/2002	CN1341591A Solution of tetrahydrate N-[ortho-(para-trimethyl acetoxyl benzenesulfonamide) benzoyl] glycine monosodium salt and its medicine
03/27/2002	CN1341447A Fat-reducing weight-reducing chewing gum and its production method
03/27/2002	CN1341444A Health-care product with function of regulating blood sugar and its preparation method
03/27/2002	CN1341438A Ointment for curing rhagades of hand and foot and its preparation method
03/27/2002	CN1341436A Eexternal-use Chinese medicine plaster for curing deafness and tinnitus
03/27/2002	CN1341435A Wound quick healing ointment
03/27/2002	CN1341416A Production method of aquatic product feed crystal amino acid slow-releasing preparation
03/27/2002	CN1081459C Transdermal delivery device
03/27/2002	CN1081458C Process for producing active material composition and active meterial composition
03/26/2002	US6362319 Glial cell line-derived neurotrophic factor
03/26/2002	US6362308 Solubility in methylene chloride
03/26/2002	US6362234 Water-soluble prodrugs of propofol for treatment of migrane
03/26/2002	US6362225 Influenza, rhinovirus therapy usin lysine monohydrochloride
03/26/2002	US6362219 Process for the preparation of a formulation of dihydroartemisinin for the control of wide spectrum of malaria
03/26/2002	US6362182 Hypotensive agents; anticholesterol agents; benign prostatic hypertropic
03/26/2002	US6362167 Method of blocking free radical processes which result in mediated pathology without deleterious pro-oxidant side reactions
03/26/2002	US6361938 Peptides which enhance transport across tissues and methods of identifying and using the same
03/26/2002	US6361802 Adding solvent, separtion and recovering
03/26/2002	US6361799 Surfactant of sorbitan ester of polyethylene glycol without solvent
03/26/2002	US6361798 Polymer, suspension agent and vessels
03/26/2002	US6361797 Hydrogel compositions useful for the sustained release of macromolecules and methods of making same
03/26/2002	US6361796 Soluble form osmotic dose delivery system
03/26/2002	US6361795 Method for lowering blood glucose
03/26/2002	US6361794 Granulation of ibuprofen, hydrocodone bitartrate and silica
03/26/2002	US6361792 Fluorocarbon emulsion and nonsteroid antiinflammatory agent, antipyretic, nonnarcotic analgesic
03/26/2002	US6361791 Stable aqueous dispersions including cationic lipids
03/26/2002	US6361790 Method of forming adhesive patch for applying medication to the skin
03/26/2002	US6361771 Implantable cell culture device comprising semipermeable membrane permitting diffusion of growth factor therethrough, and arpe-19 cells genetically engineered to produce growth factor disposed within semipermeable membrane
03/26/2002	US6361760 Aerosol composition comprising tricyclic compound or pharmaceutically acceptable salt thereof, liquefied hydrofluoroalkane and medium-chain fatty acid triglyceride
03/26/2002	US6361758 Cosolvent formulations
03/26/2002	US6361713 Displacing water from and decontaminating surfaces
03/26/2002	US6360743 System for dispensing pharmaceutical active compounds
03/26/2002	CA2266599C Method and composition for rewetting contact lenses and relieving eye dryness
03/26/2002	CA2230682C Sugar-free dragee-like products
03/26/2002	CA2216828C Controlled release insufflation carrier for medicaments
03/26/2002	CA2183486C Prostaglandin derivatives
03/26/2002	CA2150370C Transdermal absorption preparation
03/26/2002	CA2123645C Medical adhesive tape and tape preparation
03/26/2002	CA2097740C Product and process for treating bovine mastitis and bovine metritis
03/26/2002	CA2097176C New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof
03/26/2002	CA2072513C Lozenge or chewable tablet
03/26/2002	CA2034096C Controlled absorption naproxen formulation for once-daily administration
03/26/2002	CA2027665C Agent for preventing and treating opacity of lens
03/21/2002	WO2002022851A2 Novel tumor-associated marker
03/21/2002	WO2002022573A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
03/21/2002	WO2002022204A2 Transdermal electrotransport device and method for manufacturing same
03/21/2002	WO2002022188A1 Peritoneal dialysates
03/21/2002	WO2002022175A2 Method and composition for treating tumors by selective induction of apoptosis
03/21/2002	WO2002022174A1 A novel cationic lipopolymer as biocompatible gene delivery agent
03/21/2002	WO2002022172A2 Powdered/microfibrillated cellulose
03/21/2002	WO2002022171A2 Pharmaceutical composition having specific water activity
03/21/2002	WO2002022164A1 Composition comprising immunogenic microparticles
03/21/2002	WO2002022163A1 Remedies for ischemic diseases
03/21/2002	WO2002022158A1 Selfemulsifiable formulation having enhanced bioabsorption and immunosuppression activities
03/21/2002	WO2002022157A2 Injectable hybrid matrix mixtures
03/21/2002	WO2002022156A2 Topical formulations for delivery of interleukin-11
03/21/2002	WO2002022150A2 Medicament containing activated antithrombin iii
03/21/2002	WO2002022136A1 Diphosphonate solutions
03/21/2002	WO2002022135A1 Creatine ester pronutrient compounds and formulations
03/21/2002	WO2002022132A2 Novel topical oestroprogestational compositions with systemic effect
03/21/2002	WO2002022131A1 Eye drops
03/21/2002	WO2002022120A1 Pain reliever and method of use
03/21/2002	WO2002022110A2 Contraception process and administration form for the same
03/21/2002	WO2002022109A2 Patch comprising diclofenac
03/21/2002	WO2002022108A1 Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
03/21/2002	WO2002022107A2 Pharmaceutical composition having modified carrier
03/21/2002	WO2002022106A2 Stable ophthalmic preparation
03/21/2002	WO2002022059A1 Treatment for high pressure bleeding
03/21/2002	WO2001085845B1 Wound gels
03/21/2002	WO2001080831A3 Zero order release and temperature-controlled microcapsules and process for the preparation thereof
03/21/2002	WO2001080829A3 Taste masking coating composition
03/21/2002	WO2001080826A3 Taste masking coating composition
03/21/2002	WO2001076631A3 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
03/21/2002	WO2001070694A8 Amorphous torasemide modification
03/21/2002	WO2001070196A3 Sustained release delivery systems for solutes
03/21/2002	WO2001070195A3 A method and apparatus for coating centers
03/21/2002	WO2001068092A3 Glycogen phosphorylase inhibitor
03/21/2002	WO2001064344A3 Microfabricated devices for the storage and selective exposure of chemicals and devices
03/21/2002	WO2001060402A3 Proteosome influenza vaccine
03/21/2002	WO2001056548A3 Liposomes composition produced by a dehydration-rehydration process
03/21/2002	WO2001054662A3 Compressed microparticles for dry injection
03/21/2002	WO2001051026A3 Instant granules and process for their formulation
03/21/2002	WO2001049266A3 Iron chelator delivery system
03/21/2002	WO2001045670A3 A stable immunogenic composition for frozen storage
03/21/2002	WO2001037851A3 Use of ubiquinone q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies
03/21/2002	WO2001035943A3 Dextrose and insulin fluid formulation for intravenous infusion
03/21/2002	WO2001035940A3 Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride
03/21/2002	WO2001034196A3 Mixture containing rare earths and use thereof

1 ... 2304 2305 2306 2307 2308 2309 2310 2311 2312 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 ... 2991